biosimilars - International Pharmaceutical Industry

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

News

Pharmapack Report 2021: US leads on drug device innovation but trails Europe on sustainability

Event agenda to track trends in sustainability, patient-centered device design and biosimilars and autoinjectors Ahead of the first Pharmapack Europe to...

17 September 2021 News autoinjectors | biosimilars

Continue Reading →

News

Univercells granted €2.4M ($2.9M) to develop antibody production platform

Univercells SA, a technology company dedicated to delivering innovative and cost-effective biomanufacturing solutions, today announces that it has received a grant&...

25 January 2018 News antibody | auto-immune

Continue Reading →

News

Japanese pharma – no longer ‘lost in translation’

A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars and increa...

15 January 2018 News biosimilars | CPhI

Continue Reading →

News

BIOCAD launches the new manufacturing site in North Africa

Russian biotechnology company BIOCAD and Moroccan pharmaceutical company Sothema Labs announced the launch of medicines derived using the technology provided by the ...